Tesaglitazar, a dual peroxisome proliferator-activated receptor α/γ agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance

Published 2007 View Full Article

Authors

Keywords

Journal

ATHEROSCLEROSIS

Volume 197, Issue 1, Pages 355-362

Publisher

Elsevier BV

Online

2007-07-14

DOI

10.1016/j.atherosclerosis.2007.05.029

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

ATHEROSCLEROSIS

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find the ideal target journal for your manuscript

Become a Peeref-certified reviewer